Evidence map›Paper›PMID 29658445›Full record

ArticleMicroRNA (Shariqah, United Arab Emirates)2018

Improved Detection of Circulating miRNAs in Serum and Plasma Following Rapid Heat/Freeze Cycling.

Peter D Mariner, Armin Korst, Anis Karimpour-Fard, Brian L Stauffer, Shelley D Miyamoto, Carmen C Sucharov

Abstract read
In one paragraph

Article in MicroRNA (Shariqah, United Arab Emirates), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Circulating and Cardiac Tissue miRNAs in Children with Dilated Cardiomyopathy.Journal of cardiovascular development and disease · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peter D MarinerCoramir Biomedical, Superior, CO 80027, United States.
Armin KorstDepartment of Medicine, Division of Cardiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, United States.
Anis Karimpour-FardDepartment of Pharmacology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, United States.
Brian L StaufferDepartment of Medicine, Division of Cardiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, United States.
Shelley D MiyamotoDepartment of Pediatrics, Division of Cardiology, University of Colorado Anschutz Medical Campus, Children`s Hospital Colorado, Aurora, CO 80045, United States.
Carmen C SucharovDepartment of Medicine, Division of Cardiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, United States.

Funding

Molecular and Functional Mechanisms of Pediatric Heart FailureR01HL107715 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STAUFFER, BRIAN L · 2012 to 2016
$2.8M
Myocardial Effects of PDE5 Inhibition in Single Ventricle Heart DiseaseR01HL126928 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MIYAMOTO, SHELLEY DEANNE · 2015 to 2019
$2.7M
miRNA Regulation of Vascular Permeability and Inflammation in the Lung InjuryR01HL119533 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI CARPENTER, TODD C, KOMPELLA, UDAY B · 2014 to 2017
$2.5M
Non-invasive risk assessment tool for pediatric heart failureR41HL137564 · NHLBI · CORAMIR BIOMEDICAL, INC. · PI SUCHAROV, CARMEN C · 2017 to 2017
$154k
NHLBI NIH HHS R01 HL107715NHLBI NIH HHS R01 HL119533NHLBI NIH HHS R01 HL126928NHLBI NIH HHS R41 HL137564
6 · The paper itself

Abstract

backgroundThe measurement of circulating miRNAs has proven to be a powerful biomarker tool for several disease processes. Current protocols for the detection of miRNAs usually involve an RNA extraction step, requiring a substantial volume of patient serum or plasma to obtain sufficient input material.

objectiveHere, we describe a novel methodology that allows detection of a large number of miRNAs from a small volume of serum or plasma without the need for RNA extraction.

methodsThree μl of serum or plasma was subjected to three cycles of high and low temperatures (heat/freeze cycles) followed by miRNA arrays.

resultsOur results indicate that miRNA detection following this process is highly reproducible when comparing multiple samples from the same subject. Moreover, this protocol increases the reproducibility of miRNA detection in samples that were previously subjected to multiple freeze-thaw cycles. Importantly, the detection of miRNAs from serum vs. plasma following heat/freeze cycling are highly comparable, indicating that this heat/freeze process effectively eliminates differences in detection between serum and plasma samples that have been reported using other sample preparation methodologies.

conclusionWe propose that this method is a potent alternative to current RNA extraction protocols, substantially reducing the amount of sample necessary for miRNA detection while simultaneously improving miRNA detection and reproducibility.

Indexed as

BiomarkersCirculating MicroRNAFreezingHot TemperatureHumansPlasmaSerumSpecimen HandlingBiomarkersCirculating MicroRNAbiomarkerCirculating miRNAsliquid biopsymiRNA arrayplasmaserum.

Identifiers

PMID29658445
PMCPMC6198569

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.